Abstract
BackgroundThe use of probiotic supplementation by cancer patients is increasing, including amongst those undergoing immune checkpoint inhibitor (ICI) therapy. While probiotic supplementation has been identified as an important factor influencing...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
